Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion
- Status
- UNKNOWN
- Phase
- PHASE2
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3